Species | Target name | Source | Bibliographic reference |
---|---|---|---|
Homo sapiens | GNAS complex locus | Starlite/ChEMBL | No references |
Species | Potential target | Known druggable target | Length | Alignment span | Identity |
---|---|---|---|---|---|
Schistosoma mansoni | GTP-binding protein alpha subunit gna | GNAS complex locus | 394 aa | 450 aa | 28.7 % |
Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Plasmodium vivax | hypothetical protein, conserved | 0.0035 | 0.0652 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0652 | 0.192 |
Mycobacterium leprae | Probable lipase LipE | 0.0035 | 0.0652 | 0.5 |
Mycobacterium leprae | conserved hypothetical protein | 0.0035 | 0.0652 | 0.5 |
Schistosoma mansoni | bromodomain containing protein | 0.0067 | 0.2237 | 0.2473 |
Echinococcus multilocularis | beta LACTamase domain containing family member | 0.0035 | 0.0652 | 0.1675 |
Loa Loa (eye worm) | hypothetical protein | 0.0045 | 0.1155 | 0.34 |
Schistosoma mansoni | amine GPCR | 0.0204 | 0.9045 | 1 |
Schistosoma mansoni | acetyl-CoA C-acetyltransferase | 0.0024 | 0.01 | 0.0111 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0652 | 0.192 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0652 | 0.5 |
Brugia malayi | Bromodomain containing protein | 0.0041 | 0.0927 | 0.2214 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0652 | 0.5 |
Brugia malayi | GTP-binding regulatory protein Gs alpha-S chain, putative | 0.009 | 0.3396 | 1 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.009 | 0.3396 | 1 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0652 | 0.192 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0035 | 0.0652 | 0.5 |
Mycobacterium ulcerans | esterase/lipase LipP | 0.0035 | 0.0652 | 0.5 |
Brugia malayi | beta-lactamase family protein | 0.0035 | 0.0652 | 0.1349 |
Loa Loa (eye worm) | hypothetical protein | 0.0075 | 0.2628 | 0.7737 |
Loa Loa (eye worm) | hypothetical protein | 0.0041 | 0.093 | 0.274 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.009 | 0.3396 | 0.3755 |
Onchocerca volvulus | 0.0035 | 0.0652 | 0.5 | |
Toxoplasma gondii | ABC1 family protein | 0.0035 | 0.0652 | 0.5 |
Mycobacterium ulcerans | fusion of enoyl-CoA hydratase, EchA21 and lipase, LipE | 0.0035 | 0.0652 | 0.5 |
Trypanosoma brucei | hypothetical protein, conserved | 0.0035 | 0.0652 | 0.5 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0038 | 0.0803 | 0.2131 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0652 | 0.192 |
Trichomonas vaginalis | esterase, putative | 0.0035 | 0.0652 | 0.5 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0035 | 0.0652 | 0.0721 |
Mycobacterium ulcerans | hypothetical protein | 0.0035 | 0.0652 | 0.5 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0652 | 0.5 |
Echinococcus granulosus | guanine nucleotide binding protein Gs subunit | 0.009 | 0.3396 | 1 |
Trypanosoma cruzi | hypothetical protein, conserved | 0.0035 | 0.0652 | 0.5 |
Mycobacterium ulcerans | beta-lactamase | 0.0035 | 0.0652 | 0.5 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0063 | 0.2049 | 0.5914 |
Schistosoma mansoni | family S12 unassigned peptidase (S12 family) | 0.0035 | 0.0652 | 0.0721 |
Loa Loa (eye worm) | hypothetical protein | 0.0043 | 0.1055 | 0.3105 |
Mycobacterium ulcerans | lipase LipD | 0.0035 | 0.0652 | 0.5 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0652 | 0.192 |
Loa Loa (eye worm) | hypothetical protein | 0.0035 | 0.0652 | 0.192 |
Brugia malayi | beta-lactamase family protein | 0.0035 | 0.0652 | 0.1349 |
Trichomonas vaginalis | D-aminoacylase, putative | 0.0035 | 0.0652 | 0.5 |
Loa Loa (eye worm) | GTP-binding regulatory protein Gs alpha-S chain | 0.009 | 0.3396 | 1 |
Echinococcus multilocularis | bromodomain adjacent to zinc finger domain | 0.0038 | 0.0803 | 0.2131 |
Onchocerca volvulus | 0.0035 | 0.0652 | 0.5 | |
Brugia malayi | Bromodomain containing protein | 0.0079 | 0.2852 | 0.8284 |
Brugia malayi | Hypothetical 52.5 kDa protein ZK945.1 in chromosome II, putative | 0.0035 | 0.0652 | 0.1349 |
Onchocerca volvulus | 0.0035 | 0.0652 | 0.5 | |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.009 | 0.3396 | 0.3755 |
Echinococcus granulosus | beta LACTamase domain containing family member | 0.0035 | 0.0652 | 0.1675 |
Echinococcus granulosus | bromodomain adjacent to zinc finger domain | 0.0063 | 0.2049 | 0.5914 |
Brugia malayi | beta-lactamase | 0.0035 | 0.0652 | 0.1349 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.009 | 0.3396 | 1 |
Echinococcus multilocularis | guanine nucleotide binding protein G(s) subunit | 0.009 | 0.3396 | 1 |
Schistosoma mansoni | Guanine nucleotide-binding protein G(s) subunit alpha (Adenylate cyclase-stimulating G alpha protein) | 0.009 | 0.3396 | 0.3755 |
Leishmania major | hypothetical protein, conserved | 0.0035 | 0.0652 | 0.5 |
Trichomonas vaginalis | penicillin-binding protein, putative | 0.0035 | 0.0652 | 0.5 |
Loa Loa (eye worm) | beta-LACTamase domain containing family member | 0.0035 | 0.0652 | 0.192 |
Loa Loa (eye worm) | beta-lactamase | 0.0035 | 0.0652 | 0.192 |
Activity type | Activity value | Assay description | Source | Reference |
---|---|---|---|---|
Potency (functional) | 4.4668 uM | PubChem BioAssay. qHTS for Agonist of gsp, the Etiologic Mutation Responsible for Fibrous Dysplasia/McCune-Albright Syndrome: qHTS. (Class of assay: confirmatory) | ChEMBL. | No reference |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.